Holen Sie sich die Stockscreener-App
11.12
2.68%
0.295
Schlusskurs vom Vortag:
$10.82
Offen:
$10.62
24-Stunden-Volumen:
503.52K
Relative Volume:
0.76
Marktkapitalisierung:
$237.51M
Einnahmen:
$66.59M
Nettoeinkommen (Verlust:
$-104.93M
KGV:
-2.2455
EPS:
-4.95
Netto-Cashflow:
$-96.48M
1W Leistung:
+6.11%
1M Leistung:
+7.55%
6M Leistung:
+86.72%
1J Leistung:
+0.00%
1-Tages-Spanne:
$10.56
$11.34
1-Wochen-Bereich:
$10.33
$11.45
52-Wochen-Spanne:
$4.09
$15.34
Enanta Pharmaceuticals Inc Stock (ENTA) Company Profile
Firmenname
Enanta Pharmaceuticals Inc
Sektor
Branche
Telefon
617 607 0800
Adresse
4 KINGSBURY AVENUE, WATERTOWN, MA
Vergleichen Sie ENTA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENTA
Enanta Pharmaceuticals Inc
|
11.11 | 312.19M | 66.59M | -104.93M | -96.48M | -4.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.22 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.22 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.73 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.59 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.82 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Enanta Pharmaceuticals Inc Stock (ENTA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-01 | Hochstufung | Jefferies | Hold → Buy |
| 2025-07-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2023-08-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-08-08 | Herabstufung | Jefferies | Buy → Hold |
| 2022-12-09 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-07-06 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-10-07 | Eingeleitet | Jefferies | Buy |
| 2021-09-09 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-01-29 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2020-11-24 | Eingeleitet | Evercore ISI | Underperform |
| 2020-08-28 | Fortgesetzt | ROTH Capital | Buy |
| 2020-08-26 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-27 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2020-03-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-11-22 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-09-26 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2019-05-24 | Eingeleitet | Wolfe Research | Outperform |
| 2019-04-23 | Hochstufung | Berenberg | Hold → Buy |
| 2018-12-13 | Eingeleitet | Berenberg | Hold |
| 2018-06-06 | Eingeleitet | ROTH Capital | Buy |
| 2018-02-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-01-02 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2017-11-21 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-09-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2017-07-11 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-04-28 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2016-02-09 | Bestätigt | Barclays | Underweight |
| 2015-10-23 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2015-10-23 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
Alle ansehen
Enanta Pharmaceuticals Inc Aktie (ENTA) Neueste Nachrichten
Enanta Pharmaceuticals to Participate in Upcoming Investor Conferences - Yahoo Finance
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) has caught the attention of institutional investors who hold a sizeable 44% stake - Yahoo Finance
What sentiment indicators say about Enanta Pharmaceuticals Inc. stockPortfolio Risk Report & Comprehensive Market Scan Insights - newser.com
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
What does recent volatility data suggest for Enanta Pharmaceuticals Inc.Options Play & Daily Profit Focused Stock Screening - newser.com
What the charts say about Enanta Pharmaceuticals Inc. todayTrade Signal Summary & Consistent Profit Trade Alerts - newser.com
Is Enanta Pharmaceuticals Inc. stock ready for a breakoutQuarterly Trade Report & Technical Entry and Exit Tips - newser.com
How Enanta Pharmaceuticals Inc. stock performs in rising dollar environmentRate Hike & Daily Growth Stock Investment Tips - newser.com
Why Enanta Pharmaceuticals Inc. stock is rated strong buyLayoff News & Free Weekly Chart Analysis and Trade Guides - newser.com
Is Enanta Pharmaceuticals Inc. stock positioned well for digital economyQuarterly Portfolio Review & Precise Trade Entry Recommendations - newser.com
How Enanta Pharmaceuticals Inc. stock compares to growth peersMarket Volume Report & AI Enhanced Trading Alerts - newser.com
Using Ichimoku Cloud for Enanta Pharmaceuticals Inc. technicals2025 Geopolitical Influence & Weekly Top Performers Watchlists - newser.com
How Enanta Pharmaceuticals Inc. stock benefits from strong dollar2025 Earnings Impact & AI Enhanced Trading Signals - newser.com
Tools to assess Enanta Pharmaceuticals Inc.’s risk profileStock Surge & Free Technical Confirmation Trade Alerts - newser.com
Is Enanta Pharmaceuticals Inc. stock supported by strong cash flowsJuly 2025 Trade Ideas & Verified Entry Point Detection - newser.com
Trend analysis for Enanta Pharmaceuticals Inc. this weekJuly 2025 Momentum & Expert Curated Trade Setup Alerts - newser.com
How to use a screener to detect Enanta Pharmaceuticals Inc. breakoutsPortfolio Profit Report & Free Community Consensus Stock Picks - newser.com
Why Enanta Pharmaceuticals Inc. (9EP) stock gets analyst attentionQuarterly Market Summary & Weekly Chart Analysis and Guides - newser.com
How to forecast Enanta Pharmaceuticals Inc. trends using time seriesJuly 2025 Rallies & Long-Term Investment Growth Plans - newser.com
Will breakout in Enanta Pharmaceuticals Inc. lead to full recoveryJuly 2025 Analyst Calls & Weekly Stock Breakout Alerts - newser.com
Can Enanta Pharmaceuticals Inc. (9EP) stock deliver strong annual returnsTrade Volume Report & Growth Oriented Trade Recommendations - newser.com
Is Enanta Pharmaceuticals Inc. stock a good choice for value investorsStock Surge & Stock Portfolio Risk Control - newser.com
Will earnings trigger a reversal in Enanta Pharmaceuticals Inc.2025 Big Picture & Daily Stock Trend Watchlist - newser.com
How reliable is Enanta Pharmaceuticals Inc. (9EP) stock dividend growth2025 Analyst Calls & Technical Pattern Alert System - newser.com
What drives Enanta Pharmaceuticals Inc 9EP stock priceStraddle and Strangle Trades & Lower Drawdowns With Smart Position Sizing - earlytimes.in
How institutional buying supports Enanta Pharmaceuticals Inc. stockQuarterly Trade Report & Growth Focused Entry Reports - newser.com
Can Enanta Pharmaceuticals Inc. stock resist market sell offsDip Buying & Safe Swing Trade Setups - newser.com
Is Enanta Pharmaceuticals Inc. stock attractive for retirement portfoliosDay Trade & Stepwise Swing Trade Plans - newser.com
How Enanta Pharmaceuticals Inc. stock compares to industry benchmarksWeekly Trade Review & Community Consensus Stock Picks - newser.com
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Not Doing Enough For Some Investors As Its Shares Slump 30% - simplywall.st
Finanzdaten der Enanta Pharmaceuticals Inc-Aktie (ENTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.19%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):